Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...

Full description

Bibliographic Details
Main Authors:	Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
by: Bain, P, et al.
Published: (1996)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
by: Lang, B
Published: (2007)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
by: Lang, B, et al.
Published: (2013)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
by: Maddison, P, et al.
Published: (2001)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
by: Motomura, M, et al.
Published: (1997)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
by: Squier, M, et al.
Published: (1991)

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
by: Payne, M, et al.
Published: (2010)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
by: Pinto, A, et al.
Published: (2002)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
by: Cruz, M, et al.
Published: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
by: Palace, J, et al.
Published: (2004)

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article
by: Paulo José Lorenzoni, et al.

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
by: Lang, B, et al.
Published: (2008)

Lambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newborn
by: N. I. Shcherbakova, et al.
Published: (2015-02-01)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
by: Lorenzoni, P, et al.
Published: (2008)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
by: Titulaer, M, et al.
Published: (2011)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
by: Yutaka Furukawa, et al.
Published: (2022-09-01)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome
by: Rob Zielinski, et al.
Published: (2021-08-01)

Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
by: Sumera Bukhari MD, et al.
Published: (2017-07-01)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
by: Maddison, P, et al.
Published: (2011)

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
by: Wirtz, P, et al.
Published: (2003)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
by: Titulaer, M, et al.
Published: (2010)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
by: Teppei Komatsu, et al.
Published: (2013-01-01)

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome
by: SUN Qing, et al.
Published: (2024-10-01)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
by: Vincent, A
Published: (2008)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
by: Lehnerer, S, et al.
Published: (2024)

Electron microscopic study of skeletal muscle in the Lambert–Eaton myasthenic syndrome
by: L. L. Babakova, et al.
Published: (2015-02-01)

Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
by: Shalesh Rohatgi, et al.
Published: (2024-06-01)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
by: Pascuzzi RM, et al.
Published: (2022-12-01)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases
by: Paulo J. Lorenzoni, et al.
Published: (2010-12-01)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
by: Wirtz, P, et al.
Published: (2005)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
by: Scott P. Ginebaugh, et al.
Published: (2022-05-01)

Truncal Ataxia: An Overlooked Symptom in Patients with Lambert–Eaton Myasthenic Syndrome in the Early Stage
by: Betül Özenç, et al.
Published: (2024-06-01)

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
by: Briggs SEW, et al.
Published: (2013-05-01)

Lambert-Eaton myasthenic syndrome against the background of thyroid cancer: a clinical case
by: Elena V. Khozhenko, et al.
Published: (2024-04-01)

Phoneutria nigriventer ω-Phonetoxin IIA: A new tool for anti-calcium channel autoantibody assays in Lambert–Eaton myasthenic syndrome
by: Nicole Martin-Moutot, et al.
Published: (2006-04-01)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
by: Wirtz, P, et al.
Published: (2005)

Lambert-Eaton Syndrome in Children
by: J Gordon Millichap, et al.
Published: (2014-02-01)

Spontaneously resolving paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome in association with treatment-sensitive Lambert-Eaton myasthenic syndrome
by: Simister, R, et al.
Published: (2006)

Lambert-Eaton Myasthenic Syndrome: A Review of Rare Neuromuscular Disease Related to Paraneoplastic and Autoimmune
by: Ichlasul Mahdi Fardhani, et al.
Published: (2025-01-01)

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
by: Naoya Ishibashi, et al.
Published: (2024-01-01)